Navigation Links
ImaRx Provides Update on TUCSON Phase I/II Clinical Trial in Acute Ischemic Stroke
Date:1/4/2008

f this important stroke therapy."

Future Development Plans

The Company intends to initiate its next SonoLysis clinical study in the second half of 2008. To avoid the inherent bleeding risk associated with tPA, the Company intends to conduct its future clinical trials under its SEDONA program, MRX-801 microbubbles and ultrasound, without tPA. Prior to commencing the trials, the Company intends to conduct its previously announced pre- clinical studies designed to further optimize the ultrasound delivery parameters.

"Concluding the TUCSON study ahead of schedule allows us early access to data and helps us to reduce our expenses," said Bradford A. Zakes, President and CEO of ImaRx Therapeutics. "We look forward to the continued advancement of our SonoLysis technology for stroke under our SEDONA program."

About ImaRx Therapeutics

ImaRx Therapeutics is a biopharmaceutical company developing and commercializing therapies for vascular disorders. The Company's research and development efforts are focused on therapies for stroke and other vascular disorders using its proprietary microbubble technology. ImaRx Therapeutics' commercialization efforts are currently focused on its product, urokinase, for the treatment of acute massive pulmonary embolism.

Cautionary Statement For The Purpose Of The "Safe Harbor" Provisions Of The Private Securities Litigation Reform Act of 1995

Note: Statements made in this press release which are not historical in nature constitute forward-looking statements for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. Such statements include those related to our belief that the intracranial hemorrhage events, such as those observed in Cohort 2, may be reduced by eliminating tPA in our future SonoLysis clinical studies in stroke, our intention to initiate the next SonoLysis clinical study in the second half of 2008 and our intention to conduct previously announced
'/>"/>

SOURCE ImaRx Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Progen Provides Update on Phase 3 Clinical Program for PI-88 in Liver Cancer
2. IDM Pharma Provides Update of Product Pipeline and Announces Plans to Evaluate Strategic Alternatives for the Company
3. NicOx Completes Enrollment in Second Pivotal Phase 3 Study for Naproxcinod and Provides Development Update
4. Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery
5. Replidyne Provides Strategic Update
6. BioCryst Provides Forodesine HCl Update
7. Celtic Pharma Provides Update on XERECEPT(R) Clinical Program
8. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
9. Sinovac Provides Update in Pandemic Influenza Vaccines (H5N1) Phase II Clinical Trials
10. Isis Reports New Data for Mipomersen in Routine High Cholesterol Patients and Provides Cumulative Safety Summary
11. Improved Cornea Surgery Technique Provides Enhanced Transplant Success
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...WN, W.Va., Sept. 5 /PRNewswire-USNewswire/ -- Canc...ntal fog known as chemobrain. Now in,animal studie...scovered,that injections of N-acetyl cysteine (NAC...t breast cancer chemotherapy drugs sometimes induc...he September issue of the,journal Metabolic Brain ...
(Date:9/5/2008)...Demonstrates microRNAs Extracted From a Simple Blo...linical Biomarkers for a Wide Range of ...ry Technology, Rosetta Genomics is Currently Devel...olon Cancer, REHOVOT, Israel and JERSEY CITY, New...etta Genomics, Ltd. (NASDQ: ROSG), a leader in,the...
(Date:9/4/2008)...he first in TaqMan(R) real-time PCR testing for th... PLEASANTON, Calif., Sept. 4 /- The ... the Roche COBAS(R) TaqMan(R) HBV Test,the first ...ved in the U.S.,The test uses Roche,s real-time PC... virus DNA in a patient,s blood. Doctors may use v...
(Date:9/4/2008)...dy Seeks to Enroll 750 Women at More Than 100 Site...ire/ -- QuatRx Pharmaceuticals, a,privately-held b...d,commercialization of compounds to treat endocrin...nnounced that it has initiated a second,Phase 3 cl...he company,s,estrogen-free oral therapy in develop...
Breaking Medicine Technology:Study Suggests a Possible Way to Offset Chemobrain Memory Loss 2Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 2Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 3Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 4FDA Approves First Hepatitis B Viral Load Test 2FDA Approves First Hepatitis B Viral Load Test 3QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 2QuatRx Initiates Second Phase 3 Study of Ophena(TM) (Ospemifene Tablets) in Women With Postmenopausal Vaginal Syndrome 3S BIO Receives Orphan Drug Designation for JAK2 Inhibitor SB1518 for the Treatment of Myeloproliferative Disorders 5335 1S BIO Receives Orphan Drug Designation for JAK2 Inhibitor SB1518 for the Treatment of Myeloproliferative Disorders 5335 2SGX Pharmaceuticals Announces First Quarter Financial Results and Gives Pipeline Update 5334 1SGX Pharmaceuticals Announces First Quarter Financial Results and Gives Pipeline Update 5334 2SGX Pharmaceuticals Announces First Quarter Financial Results and Gives Pipeline Update 5334 3SGX Pharmaceuticals Announces First Quarter Financial Results and Gives Pipeline Update 5334 4SGX Pharmaceuticals Announces First Quarter Financial Results and Gives Pipeline Update 5334 5SGX Pharmaceuticals Announces First Quarter Financial Results and Gives Pipeline Update 5334 6SGX Pharmaceuticals Announces First Quarter Financial Results and Gives Pipeline Update 5334 7SGX Pharmaceuticals Announces First Quarter Financial Results and Gives Pipeline Update 5334 8Updated Microsoft Health Common User Interface Furthers Clinical Effectiveness Increases Patient Safety 19141 1Updated Microsoft Health Common User Interface Furthers Clinical Effectiveness Increases Patient Safety 19141 2Updated Microsoft Health Common User Interface Furthers Clinical Effectiveness Increases Patient Safety 19141 3Samplify Systems Announces Availability of Compression for Computed Tomography 3B Integrated Slip Ring Solution to be Jointly Developed with Schleifri 19139 1Samplify Systems Announces Availability of Compression for Computed Tomography 3B Integrated Slip Ring Solution to be Jointly Developed with Schleifri 19139 2Samplify Systems Announces Availability of Compression for Computed Tomography 3B Integrated Slip Ring Solution to be Jointly Developed with Schleifri 19139 3Samplify Systems Announces Availability of Compression for Computed Tomography 3B Integrated Slip Ring Solution to be Jointly Developed with Schleifri 19139 4
...07 /PRNewswire-FirstCall/ -- Alexza,Pharmaceutical...e,49th Annual American Headache Society Meeting th...o(R) prochlorperazine (AZ-001),for the acute treat..., "Efficacy and tolerability profile of AZ-001,(St... headache",(Poster S-72), will be available for vi...
...ay 31, 2007 /PRNewswire-FirstCall/,- OncoGenex Tec...y,announced that preliminary data from ongoing cli...American Society of Clinical,Oncology Annual Meeti...Phase II clinical study of OGX-011 in hormone refr...clinical study of,OGX-011 in non-small cell lung c...
Other Medicine Technology:Alexza Pharmaceuticals to Present AZ-001 Phase IIb Clinical Data at,the American Headache Society Meeting 2OncoGenex and Isis Announce OGX-011 Data to be Presented at ASCO 2OncoGenex and Isis Announce OGX-011 Data to be Presented at ASCO 3OncoGenex and Isis Announce OGX-011 Data to be Presented at ASCO 4
(Date:9/8/2008)...aser scalpels, arthroscopic,surgery, genomic resea...rinary medicine is quickly expanding into new high...e benefit; it,s improving medicine for,people, too... care for their pets to,treat diseases like diabet... according to the American Veterinary Medical Asso...
(Date:9/8/2008)...zine examines Iraq and Afghanistan veterans, strug..., Washington, DC (PRWEB) S...by veterans of the Iraq and Afghanistan wars about... addiction disorders are featured in the current i...ublication of the National Council for Community B...
(Date:9/7/2008)...f older patients successfully treated for colorect...le to detect any recurrence of cancer. The study, ... , a peer-reviewed journal of the American Cancer ...monitoring of colorectal cancer survivors could af...y curative surgery for colorectal cancer have an i...
(Date:9/7/2008)... appear to lower a man,s PSA level, the blood biom...her a man is at risk of prostate cancer. , But t.... 8 in the journal Cancer , caution that men shou... prostate cancer just yet. , "We showed that me...rin and other non-steroidal anti-inflammatory drug...
Breaking Medicine News(10 mins):Health News:High-Tech Vet Medicine Saving Lives of Pets and People 2Health News:Helping Veterans in Our Communities 2Health News:Helping Veterans in Our Communities 3Health News:Many colorectal cancer survivors do not receive recommended follow-up care 2Health News:Common painkillers lower levels of prostate cancer biomarker 2
... U.S prescription use released last week revealed ...tion// for Attention Deficiency Hyperactivity Diso...f a similar prescription themselves. In the year 2... children and their parents were studied by resear...
...tarted to dissuade and at times even forbid birthd...sity. // "They can bring carrots," said Laura Ott,...thday girl, Cassidy Stewart received a card, a sti...s from her classmates. Her school; Mission Viejo o...
...severe coronary artery disease live longer if they...nitial treatment // instead of artery-opening angi...University Medical Center analysis. Yet up to 40 ...ere coronary disease are treated first with angiop...
...a low-carb diet replacing starches and sugars with...hey may do something radically different. // A re...ests that the major change in eating patterns for ...been the addition of large amounts of vegetables a...
Other Medicine News:Health News:Bypass Surgery, a Better Option than Angioplasty for Severe Heart Patients 2Health News:Bypass Surgery, a Better Option than Angioplasty for Severe Heart Patients 3Health News:Low-Carb Dieters Eat More Vegetables 2
EDM Lumbar Drainage Kit with and without Bioglide are fabricated of radiopaque (barium impregnated) silicone tubing, and are packaged with stainless steel stylets inserted in the lumen.
Lumbar External Drainage System (LED) with Touhy needle is indicated for temporary access to the Lumbar Subarachnoid region as a means of draining cerebral spinal fluid (CSF) in order to reduce incre
...ppi-Wells and Universal tongs were developed for s...than can be safely provided for with a standard ha...ete with four skull pins and S hook. Two, three or...ssure indicating skull pins. Universal tong includ...
First access to the skull by trepanation. Excellent handling and innovative ergonomic design. High performance motor at standard operating pressure: 6 bars (87 psi). Quick locking Hudson style coupli
Medicine Products: